Literature DB >> 27100703

Interaction of the renin angiotensin and cox systems in the kidney.

Syed S Quadri1, Silas A Culver1, Caixia Li1, Helmy M Siragy2.   

Abstract

Cyclooxygenase-2 (COX-2) plays an important role in mediating actions of the renin-angiotensin system (RAS). This review sheds light on the recent developments regarding the complex interactions between components of RAS and COX-2; and their implications on renal function and disease. COX-2 is believed to counter regulate the effects of RAS activation and therefore counter balance the vasoconstriction effect of Ang II. In kidney, under normal conditions, these systems are essential for maintaining a balance between vasodilation and vasoconstriction. However, recent studies suggested a pivotal role for this interplay in pathology. COX-2 increases the renin release and Ang II formation leading to increase in blood pressure. COX-2 is also associated with diabetic nephropathy, where its upregulation in the kidney contributes to glomerular injury and albuminuria. Selective inhibition of COX-2 retards the progression of renal injury. COX-2 also mediates the pathologic effects of the (Pro)renin receptor (PRR) in the kidney. In summary, this review discusses the interaction between the RAS and COX-2 in health and disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27100703      PMCID: PMC5119519          DOI: 10.2741/s459

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  80 in total

1.  Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet.

Authors:  P Harding; D H Sigmon; M E Alfie; P L Huang; M C Fishman; W H Beierwaltes; O A Carretero
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

2.  Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.

Authors:  Huifang Cheng; Xiaofeng Fan; Gilbert W Moeckel; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2011-07       Impact factor: 10.121

3.  Renal medullary cyclooxygenase-2 and (pro)renin receptor expression during angiotensin II-dependent hypertension.

Authors:  Alexis A Gonzalez; Torrance Green; Christina Luffman; Camille R T Bourgeois; L Gabriel Navar; Minolfa C Prieto
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

4.  AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy.

Authors:  Christine Koulis; Bryna S M Chow; Maria McKelvey; Ulrike M Steckelings; Thomas Unger; Vicki Thallas-Bonke; Merlin C Thomas; Mark E Cooper; Karin A Jandeleit-Dahm; Terri J Allen
Journal:  Hypertension       Date:  2015-03-16       Impact factor: 10.190

5.  Increased expression of renal cyclooxygenase-2 and neuronal nitric oxide synthase in hypertensive Cx40-deficient mice.

Authors:  Nathalie Krattinger; Florian Alonso; Alessandro Capponi; Lucia Mazzolai; Pascal Nicod; Paolo Meda; Jacques-Antoine Haefliger
Journal:  J Vasc Res       Date:  2008-09-24       Impact factor: 1.934

6.  Role of renal prostaglandin E2 in two-kidney, one-clip renovascular hypertension in rabbits.

Authors:  M Yoshida; H Soejima; S Ueda; K Ikegami
Journal:  Nephron       Date:  1986       Impact factor: 2.847

Review 7.  Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.

Authors:  J Zhuo; I Moeller; T Jenkins; S Y Chai; A M Allen; M Ohishi; F A Mendelsohn
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

8.  Regulation of jejunal sodium and water absorption by angiotensin subtype receptors.

Authors:  X H Jin; Z Q Wang; H M Siragy; R L Guerrant; R M Carey
Journal:  Am J Physiol       Date:  1998-08

9.  Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.

Authors:  Liffert Vogt; Dick de Zeeuw; Arend Jan J Woittiez; Gerjan Navis
Journal:  Nephrol Dial Transplant       Date:  2008-11-26       Impact factor: 5.992

10.  Role of microsomal prostaglandin E synthase 1 in the kidney.

Authors:  Helene Francois; Carie Facemire; Anil Kumar; Laurent Audoly; Beverly Koller; Thomas Coffman
Journal:  J Am Soc Nephrol       Date:  2007-04-18       Impact factor: 10.121

View more
  8 in total

1.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

Review 2.  Non-genetic mechanisms of diabetic nephropathy.

Authors:  Qiuxia Han; Hanyu Zhu; Xiangmei Chen; Zhangsuo Liu
Journal:  Front Med       Date:  2017-09-04       Impact factor: 4.592

Review 3.  An Outline of Renal Artery Stenosis Pathophysiology-A Narrative Review.

Authors:  Lukasz Dobrek
Journal:  Life (Basel)       Date:  2021-03-07

Review 4.  Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment.

Authors:  Jose L Labandeira-Garcia; Carmen M Labandeira; Rita Valenzuela; Maria A Pedrosa; Aloia Quijano; Ana I Rodriguez-Perez
Journal:  Biomedicines       Date:  2022-02-21

Review 5.  Cardiorenal Disease in COVID-19 Patients.

Authors:  Muhtasham Sifaat; Pinak Patel; Razan Sheikh; Dawood Ghaffar; Hitesh Vaishnav; Ludmila Nahar; Sonia Rupani; Syed Quadri
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2022-03-18       Impact factor: 1.636

Review 6.  Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors.

Authors:  Hajaralsadat Hosseini-Dastgerdi; Fatemeh Kharazmi; Ali-Asghar Pourshanazari; Mehdi Nematbakhsh
Journal:  Int J Nephrol       Date:  2022-10-10

Review 7.  Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.

Authors:  Ewa Szczepanska-Sadowska; Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

8.  Connexin Signaling in the Juxtaglomerular Apparatus (JGA) of Developing, Postnatal Healthy and Nephrotic Human Kidneys.

Authors:  Ivona Kosovic; Natalija Filipovic; Benjamin Benzon; Ivana Bocina; Merica Glavina Durdov; Katarina Vukojevic; Marijan Saraga; Mirna Saraga-Babic
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.